Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
10.96
+0.19 (1.76%)
Nov 4, 2024, 4:00 PM EST - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 23 employees as of December 31, 2023. The number of employees decreased by 1 or -4.17% compared to the previous year.
Employees
23
Change (1Y)
-1
Growth (1Y)
-4.17%
Revenue / Employee
$41,767
Profits / Employee
$208,904
Market Cap
9.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
XWELL | 337 |
Mustang Bio | 80 |
NKGen Biotech | 63 |
Jaguar Health | 49 |
Brainstorm Cell Therapeutics | 29 |
Ensysce Biosciences | 7 |
GlucoTrack | 6 |
ADXN News
- 5 weeks ago - Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit - GlobeNewsWire
- 2 months ago - Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Crude Oil Dips; Addex Therapeutics Shares Spike Higher - Benzinga
- 2 months ago - Why Addex Therapeutics stock skyrocketed 70% on Tuesday - Invezz
- 2 months ago - Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration - GlobeNewsWire
- 3 months ago - Addex's Partner Discontinues ADX71149 development in Epilepsy - GlobeNewsWire